EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab

Geun-Ho Park, Sehhoon Park, Hyemin Kim, Hyun-Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon Lee

European Journal of Cancer · 2025-08 · 226 · 115631

DOI: 10.1016/j.ejca.2025.115631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025-08. Verfasst von Geun-Ho Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, Re…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug Resistance, Neoplasm, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare, Ministry of Science and ICT, South Korea, Korea Institute of Science and Technology Information.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsDrug Resistance, NeoplasmBiomarkers, TumorHumansMaleFemaleErbB ReceptorsMiddle AgedAgedProspective StudiesHigh-Throughput Nucleotide SequencingExonsAdultLongitudinal StudiesAged, 80 and overCirculating Tumor DNAMutagenesis, InsertionalProgression-Free SurvivalProtein Kinase Inhibitors

Stichwörter der Autor:innen

AmivantamabCf-NGSEGFRExon 20 insertion

Substanzen

ErbB ReceptorsEGFR protein, humanBiomarkers, TumorCirculating Tumor DNAProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea; Division of Hematology-Oncology, Department of Medici…
  • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Förderung

  • Ministry of Health and Welfare
  • Ministry of Science and ICT, South Korea
  • Korea Institute of Science and Technology Information
  • National Research Foundation
  • Korea Health Industry Development Institute
  • Korea Research Environment Open Network
  • Great Southern Development Commission, Government of Western Australia
  • Samsung Medical Center, Sungkyunkwan University

Zitieren

APA

Park, G. H., Park, S., Kim, H., Jung, H. A., Sun, J. M., Ahn, J. S., Ahn, M. J., & Lee, S. H. (2025). Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab. European Journal of Cancer, 226, 115631. https://doi.org/10.1016/j.ejca.2025.115631

Vancouver

Park GH, Park S, Kim H, Jung HA, Sun JM, Ahn JS, et al. Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab. European Journal of Cancer. 2025;226:115631. doi:10.1016/j.ejca.2025.115631

BibTeX
@article{Park2025,
  author = {Park, Geun-Ho and Park, Sehhoon and Kim, Hyemin and Jung, Hyun-Ae and Sun, Jong-Mu and Ahn, Jin Seok and Ahn, Myung-Ju and Lee, Se-Hoon},
  title = {Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {226},
  pages = {115631},
  doi = {10.1016/j.ejca.2025.115631}
}
Kostenlos starten →